<DOC>
	<DOC>NCT00311506</DOC>
	<brief_summary>This is an observational study to be conducted at approximately 25 sites in the United States. Approximately 25 subjects with severe obstructive CF lung disease (FVC &lt;40% predicted) will be enrolled.</brief_summary>
	<brief_title>A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Able to provide written informed consent Males or females who will be &gt;=14 years old at Visit 3 A proven diagnosis of CF as evidenced by a positive sweat test (sweat sodium or chloride &gt;60 mEq/L by quantitative pilocarpine iontophoresis), or genotype and clinical symptoms consistent with the diagnosis of CF Able to perform reproducible spirometry maneuvers at Visit 1 in accordance with the American Thoracic Society (coefficient of variation for three FEV1 maneuvers &lt;=0.2) FVC &lt;40% predicted for height, age and sex at Visit 1 On a stable regimen of chest physiotherapy (CPT) begun at least 7 days prior to Visit 1 Able to complete the 6minute walk test at Visit 1 Use of an investigational drug or device within 28 days prior to Visit 1 Experiencing an episode of severe acute respiratory failure, as determined by the investigator</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Pulmozyme</keyword>
</DOC>